Form 4: Nuo Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Scott M. Pittman, a Director and 10% owner of Nuo Therapeutics, Inc., reported multiple transactions in common stock on October 6, 2026.
Summary
- Grant/award: acquired 4,500 Second Restated Warrant (right to buy) at $1.50 ($6,750) on October 6, 2026; holds 4,500 after (Direct).
- Grant/award: acquired 458 Prepayment Restated Warrant (right to buy) at $1.50 ($687) on October 6, 2026; holds 458 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Scott M. Pittman — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Grant/award | Second Restated Warrant (right to buy) | 4,500 | $2 | $6.8K | 4,500 |
| 2026-10-06 | Grant/award | Prepayment Restated Warrant (right to buy) | 458 | $2 | $687 | 458 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Grant/award (4,500 shares) |
| 2026-10-06 | Grant/award (458 shares) |
Keywords
insider transaction, Form 4, AURX, Nuo Therapeutics, Inc., neutral, Scott M. Pittman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.